Pharmas move from bricks and mortar to open innovation with R&D hubs
After a decade of consolidation that led to blended organizations, shuttered R&D facilities and the shedding of tens of thousands of jobs, big pharma is rebuilding its internal pipeline. This time, however, the footprint looks distinctly different. Instead of constructing giant silos focused on carefully defined projects, the industry is fashioning R&D hubs with flexible designs that are close to the ground floor of discovery.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter